Strengthening Partnerships; Exploring New Markets

Thomas Arnold, managing director, Biesterfeld Spezialchemie
Thomas Arnold, managing director, Biesterfeld Spezialchemie

After a dynamic business year of 2013, we aim at further growth by tapping into new markets, intensifying existing partnerships, by acquiring new suppliers, as well as through expansion of our product portfolios and service activities, both across Europe, and in the international market.

Furthermore, Eastern and Central Europe provide interesting markets for us, with strong growth, and they will remain attractive for the future. We will grow further in Western and Northern Europe, and we see significant opportunities for growth in emerging global markets like the BRIC countries (Brazil, Russia, India and China) and Southeast Asia.

How do you intend to implement these plans and seize these opportunities?

The Europewide presence of Biesterfeld Spezialchemie and our long-term, intensive partnerships with leading suppliers contribute to a growth as well as investments in new markets and the use of synergies within the Biesterfeld Group.

Already in January 2014 we have started our activities within Biesterfeld Petroplas in the U.K. and Ireland. We plan further strategic alliances.

We see a significant boost through continuous expansion and optimization of the challenging product portfolio. Permanent adjustments to the changing market demands are a must. For example, in addition we use the possibility to advance in niche markets and satisfy the individual client's needs. In close consultation and collaboration with our subsidiaries, we intensify the market penetration and the implementation of still lacking segments of our business operations.

The expansion of our service offering and the communication - both with suppliers and customers - is top priority for us.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.